Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Erlotinib can cause hair loss as a side effect.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Keratoacanthoma comes from hair follicle cells.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Curcumin may help reverse aging by targeting specific genes.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Septin4 helps kill colon cancer cells by working with the protein BAX.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.